ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 83 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $935,000 | -39.8% | 55,900 | -5.7% | 0.12% | -44.2% |
| Q2 2015 | $1,553,000 | +17.9% | 59,300 | -21.5% | 0.22% | +17.9% |
| Q1 2015 | $1,317,000 | +16.8% | 75,500 | +15.8% | 0.18% | -3.2% |
| Q4 2014 | $1,128,000 | +200.0% | 65,200 | +221.2% | 0.19% | +239.3% |
| Q3 2014 | $376,000 | +54.1% | 20,300 | +51.5% | 0.06% | +55.6% |
| Q2 2014 | $244,000 | – | 13,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 751,012 | $3,841,000 | 3.73% |
| Healthcare Value Capital, LLC | 200,000 | $1,023,000 | 1.85% |
| DELTEC ASSET MANAGEMENT LLC | 574,886 | $2,941,000 | 0.74% |
| Kerrisdale Advisers, LLC | 229,347 | $1,173,000 | 0.74% |
| Mosaic Family Wealth, LLC | 91,314 | $609,000 | 0.25% |
| Worth Venture Partners, LLC | 77,384 | $396,000 | 0.23% |
| ARMISTICE CAPITAL, LLC | 536,000 | $2,742,000 | 0.18% |
| EMERALD ADVISERS, LLC | 639,094 | $3,269,000 | 0.15% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 609,019 | $3,115,000 | 0.14% |
| DUDLEY & SHANLEY, INC. | 67,400 | $345,000 | 0.08% |